Perlegen news from FierceBiotech
NewsPerlegen, 454 to study drug response
Perlegen Sciences and 454 Life Sciences (now owned by Roche) have teamed up to conduct large scale genetic re-sequencing Read more...
| Press ReleasesPRESS RELEASE: Perlegen and 454 to Collaborate in Drug Response Sequencing Study Perlegen and 454 to Collaborate in Drug Response Sequencing Study Novel Study Design Tests New Pharmacogenomic Approach MOUNTAIN VIEW, Calif. & BRANFORD, Conn. -- Perlegen Sciences and 454 Life Read more... |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets